Science
Mechanism of Action
This compound primarily functions by absorbing UV-B radiation, converting it into less harmful infrared energy (heat) to protect skin from sun damage, photoaging, and associated cancer risks. It can also stabilize cosmetic formulations against UV-induced deterioration. However, research indicates that when activated by light, it can directly damage DNA and increase mutagenicity, potentially contributing to sun-induced cancer despite its initial protective role.
Research
Clinical Evidence
Medium confidenceN/A
Key findings
- 01 The maximum allowed concentration in sunscreens and cosmetics in the EU, US, and Korea is 8%. A risk assessment at this concentration yielded a Margin of Safety (MOS) of 180.18, suggesting a safety margin.
- 02 Cosmetic products in Korea typically use concentrations around 1.25%, ranging from 0.5% to 2.0%.
- 03 Studies demonstrated no skin irritation on normal and damaged rabbit skin at 5% for 24 hours, and no irritation in human patch tests at 5% for 48 hours.
- 04 Human studies showed no skin sensitization at concentrations of 1.5%, 4%, and 7%, even when combined with 3% oxybenzone.
- 05 In vitro cell tests (25-100 mg/mL) revealed that Ethylhexyl Dimethyl PABA inhibited cell growth, DNA synthesis, and delayed cell cycle progression.
Transparency
Dusting Analysis
Ethylhexyl Dimethyl PABA presents significant red flags for precision skincare due to its potential for light-activated DNA damage and increased mutagenicity, directly contradicting its intended protective function. Furthermore, it is suspected to be an endocrine disruptor, carcinogen, and can generate free radicals upon photodegradation. These inherent risks make it unsuitable for formulations prioritizing ultimate skin health and safety, regardless of concentration.
The Formula
Formulation
Stability
This ingredient is an oily, yellowish liquid, insoluble in water but soluble in oil, alcohol, and strong acids/bases. Its oil-soluble nature is advantageous for emulsion and water-resistant formulations. However, it is prone to photodegradation, which diminishes its efficacy and can generate reactive free radicals; therefore, photostabilizers are typically required in formulations.
Safety
Safety Profile
The Cosmetic Ingredient Review (CIR) Panel has deferred evaluation, citing assessment by the FDA, which approves its use as an active sunscreen ingredient up to 8%. The SCCS found no estrogenic effects. However, concerns persist regarding potential organ toxicity (testis, epididymis, spleen, liver) in animal studies. It is suspected as an endocrine disruptor, carcinogen, mutagen, and can be an irritant at high concentrations. It is prone to photodegradation, reducing efficacy and producing free radicals. It is not recommended for infants or individuals with very sensitive skin and is considered 'not an unfrequent allergen' in sunscreens.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Despite its effectiveness as a UVB filter, Ethylhexyl Dimethyl PABA's documented potential for light-activated DNA damage, mutagenicity, and suspected endocrine disruption makes it unsuitable for precision skincare formulations where ultimate safety and cellular integrity are paramount.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources